Yüklüyor......
Targeted Therapies in NSCLC: Emerging oncogene targets following the success of EGFR
The diagnostic testing, treatment and prognosis of non-small cell lung cancer (NSCLC) has undergone a paradigm shift since the discovery of sensitizing mutations in the epidermal growth factor receptor (EGFR) gene in a subset of NSCLC patients. Several additional oncogenic mutations, including gene...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4159759/ https://ncbi.nlm.nih.gov/pubmed/24565585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2013.12.006 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|